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I N T R O D U C T I O N
There is scant information about the regulation of con-
nexin channels by cytoplasmic ligands, despite the im-
portance  of  gap  junction  channels  in  development, 
physiology, and disease. Identification of ligands and 
determination of their modes of action on connexin 
channels  would  be  of  considerable  value  for  under-
standing intercellular signaling pathways and for studies 
of connexin channel structure–function (Harris, 2001; 
Hervé and Sarrouilhe, 2005).
Connexin proteins compose gap junction channels. 
Because they are permeable to small cytoplasmic mole-
cules,  gap  junction  channels  mediate  a  direct  and   
intimate  form  of  intercellular  molecular  signaling. 
Junctional  channels  are  composed  of  two  hexameric 
subunits, called “hemichannels” or “connexons,” which 
dock end-to-end. These may be homo-oligomers or hetero- 
oligomers of connexins. Hemichannels are functional 
single-membrane  channels  implicated  in  a  variety  of 
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cellular processes distinct from those mediated by gap 
junction channels (Goodenough and Paul, 2003).
Many compounds affect gap junctions when applied 
to cells. However, in most cases it is unclear or unlikely 
there is direct interaction with the connexin channels 
(Harris, 2001; Hervé and Sarrouilhe, 2005; Spray et al., 
2006).  Regulation  of  some  connexin  channels  by   
pH has been well studied (Hirst-Jensen et al., 2007); 
calmodulin  regulates  some  connexin  channels,  but   
the molecular mechanism of its regulation is unknown 
(Lurtz and Louis, 2007).
Previous work using connexin hemichannels, purified 
from  rodent  tissues  and  reconstituted  into  liposomes, 
showed that the protonated forms of Good’s pH buffers 
(e.g., HEPES, MES, TAPS; Good et al., 1966) directly 
and  reversibly  inhibited  hemichannels  that  contained 
connexin26 (Cx26), whether alone (homomeric) or with 
Cx32 (heteromeric) (Bevans and Harris, 1999; Locke   
et al., 2004b; Tao and Harris, 2004). The effect of the pro-
tonated form of these buffers accounted for the apparent 
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The mechanisms of action of endogenous modulatory ligands of connexin channels are largely unknown. Previous 
work showed that protonated aminosulfonates (AS), notably taurine, directly and reversibly inhibit homomeric 
and heteromeric channels that contain Cx26, a widely distributed connexin, but not homomeric Cx32 channels. 
The present study investigated the molecular mechanisms of connexin channel modulation by taurine, using 
hemichannels and junctional channels composed of Cx26 (homomeric) and Cx26/Cx32 (heteromeric). The ad-
dition of a 28–amino acid “tag” to the carboxyl-terminal domain (CT) of Cx26 (Cx26T) eliminated taurine sensitiv-
ity of homomeric and heteromeric hemichannels in cells and liposomes. Cleavage of all but four residues of the 
tag (Cx26Tc) resulted in taurine-induced pore narrowing in homomeric hemichannels, and restored taurine inhi-
bition of heteromeric hemichannels (Cx26Tc/Cx32). Taurine actions on junctional channels were fully consistent 
with those on hemichannels. Taurine-induced inhibition of Cx26/Cx32T and nontagged Cx26 junctional channels 
was blocked by extracellular HEPES, a blocker of the taurine transporter, confirming that the taurine-sensitive site 
of Cx26 is cytoplasmic. Nuclear magnetic resonance of peptides corresponding to Cx26 cytoplasmic domains 
showed that taurine binds to the cytoplasmic loop (CL) and not the CT, and that the CT and CL directly interact. 
ELISA showed that taurine disrupts a pH-dependent interaction between the CT and the CT-proximal half of the 
CL. These studies reveal that AS disrupt a pH-driven cytoplasmic interdomain interaction in Cx26-containing 
channels, causing closure, and that the Cx26CT has a modulatory role in Cx26 function.
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investigated by nuclear magnetic resonance (NMR) 
and ELISA.
The results show that the properties of AS-induced 
closure  previously  seen  using  hemichannels  reconsti-
tuted into liposomes are also observed for hemichannels 
and junctional channels in native membranes, the latter 
having the same AS sensitivity as their component hemi-
channels. The results identify the CT of Cx26 as a key 
component  of  the  channel  modulation,  suggesting  a 
mechanism by which AS disrupts a pH-dependent asso-
ciation between the CT and cytoplasmic loop (CL) of 
Cx26, leading to occlusion of the pore.
M AT E R I A L S   A N D   M E T H O D S
Reagents
Components of the “Tet-On” connexin expression system (Koreen 
et  al.,  2004)  were  from  BD.  HEPES-buffered  DMEM  and   
bicarbonate-buffered DMEM (for experimental and maintenance 
media, respectively), penicillin, streptomycin, puromycin, G418 
sulfate, hygromycin, and doxycycline (dox) were from Life Tech-
nologies. Agarose-conjugated anti-hemagglutinin (anti-HA) clone 
HA-7 mouse IgG was from Sigma-Aldrich, as were other reagents 
unless stated otherwise. The following lipids were from Avanti 
Polar Lipids, Inc.: egg phosphatidylcholine (PC), bovine brain 
phosphatidylserine (PS), lissamine rhodamine B-labeled egg 
phosphatidylethanolamine (rhod-PE), and 1-palmitoyl-2-hydroxy-
sn-glycero-3-[phospho-RAC-(1-glycerol)] (LPPG). Detergent, n-octyl 
D-glucoside (OG; 99.5% purity), was from Glycon Biochemicals. 
Bio-Gel gel filtration matrix (A; 0.5 m; 100–200 mesh; exclusion 
limit, 500 kD) was from Bio-Rad Laboratories. Dyes, including 
CM-DiI, calcein-AM, and calcein were from Invitrogen. Peptides 
were purchased from AnaSpec, synthesized by the University of 
Medicine and Dentistry of New Jersey Molecular Research Core, 
or purified from bacteria, as outlined below.
HeLa cells stably expressing Cx26
A  HeLa  clonal  cell  line  that  stably  expresses  nontagged  Cx26   
was provided by G. Sosinsky (University of California, San Diego, 
San Diego, CA) (Hand et al., 2002; Yu et al., 2007). These cells 
were maintained in DMEM containing 10% vol/vol FBS, 100 
U/ml penicillin, 100 µg/ml streptomycin, 2 mM glutamine, and 
1 mg/ml puromycin.
Expression of tagged connexin channels in HeLa cells
Bidirectional tetracycline-responsive expression vectors (Takara 
Bio Inc.) were used to regulate expression of homomeric or het-
eromeric connexin hemichannels in HeLa cells. For homomeric 
hemichannels, rat connexin coding sequences were subcloned in-
frame with a sequence coding for a 28–amino acid CT tag consist-
ing of a thrombin cleavage site followed by a hemagglutinin 
epitope  (HA,  not  His-Ala)  and  six  repeats  of  His-Asn  (i.e., 
HA(HN)6 tag). When the two cloning sites contained different 
connexin coding sequences, only one connexin was tagged. Tet-On 
cell lines were maintained in 200 µg/ml hygromycin and 100 µg/ml 
G418. Channels are designated as Cx26T or Cx32T when homo-
meric and Cx26T/Cx32 or Cx26/Cx32T when heteromeric.
Purification of tagged connexin channels
Tet-On HeLa cells, 35% confluence at 2,000/cm
2, were induced 
for connexin expression with 1 µg/ml dox. After 48 h, cells were 
solubilized in 50 mM NaH2PO4, 50 mM NaCl, 5 mM EDTA, 5 mM 
EGTA, 80 mM OG, 1 mM -mercaptoethanol, 0.5 mM diisopropyl 
pH  sensitivity  of  the  liposome-reconstituted  channels. 
This inhibition did not occur for hemichannels com-
posed solely of Cx32. Because Good’s pH buffers are 
aminosulfonates (AS), the ubiquitous biological AS tau-
rine (-aminosulfonic acid) was tested and found to be 
inhibitory at cytoplasmic concentrations. Similar effects 
were seen for other cytoplasmic AS (e.g., hypotaurine, 
l-cysteic  acid,  l-homocysteic  acid,  l-cysteine  sulfinic 
acid). Several related cytoplasmic compounds antago-
nized this inhibition (e.g., -alanine, glycine, GABA, 
l-glutamic acid), suggesting that control of intercellular 
communication  involves  complex  interplay  among 
these compounds. The chemical requirements for the 
inhibition are well characterized; the protonated amine 
of AS is required for binding connexin, whereas the sul-
fonate moiety, and its proper distance relation to the 
amine, is necessary for the functional effect (Tao and 
Harris, 2004).
The AS effect was structurally corroborated by atomic 
force microscopy (AFM) of isolated hemichannels, re-
vealing pore closure of Cx26 channels only in the pres-
ence of protonated AS (Yu et al., 2007). The intercellular 
location of gap junction channels presents challenges 
for detailed biological and biophysical investigation; 
hemichannels have proved more amenable for study ex 
vivo and, by and large, the properties of junctional 
channels are predictable from those of the component 
hemichannels  (Harris,  2001;  Beahm  and  Hall,  2002; 
Contreras  et  al.,  2003;  Bukauskas  and  Verselis,  2004; 
Srinivas et al., 2005).
Using taurine, which is essentially fully protonated at 
physiological pH (pKa 8.8 at 37°C), the present study 
was undertaken to further define the molecular basis of 
AS inhibition of Cx26-containing channels, which are 
found in many tissues, including brain, skin, cochlea, 
liver, uterus, and liver, and whose dysfunction has a 
multitude of pathological consequences (Zhang and 
Nicholson, 1989; Willecke et al., 2002; Lee and White, 
2009; Zoidl and Dermietzel, 2010). This was addressed 
using hemichannels and gap junction channels formed 
by heterologously expressed Cx26 or Cx32, and combi-
nations, with and without an epitope tag on the carboxyl-
terminal domain (CT) (Koreen et al., 2004). This tag 
facilitated hemichannel purification for study in lipo-
somes  and  was  cleavable  by  thrombin  from  purified 
hemichannels leaving a short (four–amino acid) addi-
tion to the CT. Hemichannel activity was also assessed in 
cultured  cells  by  exploiting  the  ability  of  unpaired 
plasma membrane hemichannels to open when at low 
extracellular calcium concentrations and take up extra-
cellular dye(s) (Li et al., 1996; Quist et al., 2000). Hemi-
channel  results  from  liposome  and  cell  studies  were 
corroborated by studies of intercellular dye permeabil-
ity through junctional channels using a donor-recipient 
dye transfer assay (Goldberg et al., 1995). The specific 
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of the solutions, the bands were assigned as upper, intermediate, 
and lower on the basis of density, as determined by refractometry 
at 25°C (Locke et al., 2004a). Channel activity is assessed as the 
fraction of the liposomes that are at the lower density.
Aminosulfonate effect
The effect of AS on reconstituted hemichannel activity was assessed 
by exposure to AS during the TSF centrifugation. Any significant 
hemichannel permeability results in sufficient solute exchange to 
move liposomes to the lowest banding position. Therefore, TSF is 
an all-or-none assay of per-liposome hemichannel permeability 
and reports only conditions resulting in complete or near com-
plete pore closure. Stated another way, only complete block of 
solute permeability by AS through the connexin hemichannel 
will cause a liposome containing a functional hemichannel to re-
main at the upper position in TSF gradients. Such a change can 
be a result of pore block or of reduction to near zero channel 
open probability. Inhibition of activity because of AS is therefore 
assessed as the decrease in the fraction of liposomes in the lower 
band compared with the corresponding control.
Correction for more than one channel per liposome
A Poisson distribution describes the maximum/minimum frac-
tion of liposomes that will have functional hemichannels at differ-
ent ratios () of channels to liposomes (Rhee et al., 1996).  is 
estimated from the maximum activity observed (percentage, p, of 
liposomes with n active hemichannels; Eq. 1):
  p n e
n
n
( ) ( ).
!
. . = −λ
λ
100    (1)
As    increases,  the  fraction  of  liposomes  with  two  or  more 
hemichannels increases. Therefore, the number of liposomes in 
the TSF lower band may not accurately reflect AS sensitivity per 
hemichannel (e.g., if there are two hemichannels, both would 
have to be inhibited for a liposome to remain at the upper posi-
tion, thereby resulting in less apparent activity of a modulator). 
Using the Poisson distribution,  was used to calculate the distri-
bution of n hemichannels in the liposome population, which was 
used to compensate for the error introduced by some liposomes 
containing more than one hemichannel. This calculation trans-
forms the fraction of liposomes in the lower TSF band to the frac-
tion of hemichannels that are not inhibited.
Normalization of TSF data
For each preparation of connexin, for each experiment, the frac-
tion of liposomes in the lower TSF band was normalized to the 
maximum value obtained for that preparation. This enabled com-
parison of modulatory effects across different reconstitutions that 
produced different amounts of functional hemichannel activity 
(i.e.,  fractions  of  liposomes  with  functional  hemichannels). 
Where several preparations were used, normalized datasets were 
combined for each condition for calculation of means and stan-
dard errors.
Hemichannel uptake assay
Calcein (10 mM stock) was prepared in “low calcium buffer” 
(10 mM Tris, 120 mM NaCl, 5.6 mM KCl, 0.5 mM CaCl2, 1 mM 
MgCl2, and 11 mM glucose, pH 7.4). Semi-confluent monolayers 
(35 mm
2) were washed (10 mM Tris, 90 mM NaCl, 30 mM KCl, 
2 mM CaCl2, 1 mM MgCl2, and 11 mM glucose, pH 7.4) and, to 
assess dye uptake, cells were incubated for 30 min at 37°C with 
“loading buffer” (100 µM dye in 10 mM Tris, 120 mM NaCl, 30 mM 
KCl, 0.5 mM CaCl2, 1 mM MgCl2, and 11 mM glucose, pH 7.4). 
After 30 min, cells were washed with “normal buffer” (10 mM Tris, 
120 mM NaCl, 5.6 mM KCl, 2 mM CaCl2, 1 mM MgCl2, and 11 mM 
glucose, pH 7.4) for dye imaging under a photomicroscope 
fluorophosphate (EMD), and 0.75 mg/ml azolectin, pH 7.5, for   
2 h at 4°C with rocking. Solubilization of gap junctions with OG 
yields intact hemichannels (Lampe et al., 1991; Harris et al., 1992; 
Rhee et al., 1996; Bevans et al., 1998).
The supernatant (100,000 gav [g value averaged over length of 
centrifuge tube; e.g., at the midpoint of the tube] for 30 min at 
4°C) was incubated with 0.25 ml of agarose-immobilized anti-HA 
mouse IgG overnight at 4°C with shaking. The antibody matrix 
was collected at 700 gav (1 min at 4°C) and washed in a fritted 
column with 20 ml of 10 mM PBS, 1 M NaCl, 80 mM OG, and   
1 mg/ml azolectin, pH 7.4, followed by 20 ml of the same solution 
containing 138 mM NaCl. Hemichannels were eluted with 50 mM 
CH3COOHNa, 0.5 M NaCl, 10 mM KCl, 1 mM EDTA, and 80 mM 
OG, pH 4.0, and 0.6-ml fractions collected into 0.05 ml of 
1 M NaHCO3, 10 mM KCl, and 80 mM OG, pH 9.0. The final pH 
was 7.4.
Tag cleavage
200 µl of purified protein was incubated with 2 U of restriction-
grade thrombin (EMD) for 18 h at 4°C. Tag cleavage leaves 
four amino acids on the CT (LVPR), part of the thrombin cleav-
age site. Hemichannels with cleaved tags are designated as Cx26Tc 
or Cx32Tc when homomeric and Cx26Tc/Cx32 or Cx26/Cx32Tc 
when heteromeric.
Channel reconstitution
Immunopurified connexin hemichannels (in urea buffer, see 
below; 80 mM OG and 10 mg/ml PC/PS/rhod-PE at molar ratio 
2:1:0.01; 200 µl) were reconstituted into unilamellar liposomes by 
gel filtration in chilled, degassed urea buffer (10 mM Tris, pH 7.6, 
10 mM KCl, 0.1 mM EDTA, and 459 mM urea). Two methods 
were used, giving identical results: an 24-ml bed of 0.5 m Bio-
Gel A (100–200 mesh media; exclusion 500 kD) (Locke et al., 
2004a) or centrifugation (700 gav for 1 min at 4°C) through a 1-ml 
column of Sephadex G-50 (Heginbotham et al., 1998). The protein/
lipid ratio corresponded to an amount of connexin equivalent to 
less than one hemichannel per liposome so that, by design, some 
liposomes did not contain hemichannels.
Transport-specific fractionation (TSF) assay
TSF was used to assess the molecular selectivity of reconstituted 
connexin hemichannels (Harris et al., 1992; Rhee et al., 1996; 
Bevans et al., 1998; Bevans and Harris, 1999; Harris, 2001; Locke 
et al., 2004a,b, 2005; Tao and Harris, 2004, 2007; Ayad et al., 
2006).  TSF  fractionates  liposomes  containing  connexin  hemi-
channels into two discrete populations within an iso-osmolar den-
sity gradient, based on hemichannel permeability to urea and 
sucrose, uncharged solutes that permeate open connexin hemi-
channels and have different density at iso-osmolar concentrations 
(urea buffer, density [] = 1.0055 g/ml; when 400 mM sucrose 
replaces urea,  = 1.0511 g/ml; both 500 mOsm/kg). Liposomes 
are formed in, and entrap, urea buffer and are then centrifuged 
through linear iso-osmotic TSF density gradients formed from 
urea and sucrose buffers (300,000 gav for 3 h at 37°C; slow accel-
eration, no brake). Equilibration of these solutes across the lipo-
some through an open hemichannel occurs rapidly and increases 
the density of the liposome. TSF therefore reports all-or-nothing 
permeation of urea and sucrose through connexin hemichannels 
on a per-liposome basis. Fractionation of liposomes into bands is 
monitored by the fluorescence of rhod-PE (ex = 570 nm and 
em = 590 nm) in the liposome membrane. The typical positions 
of the upper and lower bands are centered at densities of approxi-
mately  = 1.02 g/ml and  = 1.04 g/ml, respectively. Liposomes 
that contain hemichannels permeable to one solute but not the 
other undergo osmotically driven shrinkage that results in a band 
of intermediate density of approximately  = 1.03 g/ml. Because 
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process, which might affect peptide resonance peaks during sub-
sequent experiments. The peptide was eluted from the cartridge 
with acetonitrile and lyophilized.
Purification of the Cx26 CL peptide from Escherichia coli
Rat Cx26CL, residues 99–139, was subcloned into a pet14b vector 
(EMD), providing an amino-terminal (His)6 tag and thrombin 
cleavage site, each separated by short linker sequences (HHHHHH-
SSG-LVPR-GSHM-Cx26CL),  using  flanking  EcoRI  and  BamH1 
sites. E. coli strain BL21 (DE-3; EMD) transformed with the pet14b-
Cx26CL was grown in M63 minimum media using 1 µg [
15-N]H4. 
Bacteria  (0.6  OD600)  were  induced  with  0.5  mM  isopropyl-d-
thiogalactopyranoside (for 4 h at 37°C) and pelleted at 3,500 gav 
(for 20 min at 4°C). Bacteria, resuspended in 0.1 M PBS, pH 7.4, 
containing Complete Protease Inhibitor (Roche) and 1 mM di-
thiothreitol, were lysed three times by French press. Debris was 
removed by centrifugation (3,500 gav for 10 min at 4°C), and in-
clusion bodies containing His-tagged Cx26CL were collected by 
further centrifugation (25,000 gav for 1 h at 4°C). The pellet was 
washed by centrifugation three times with 8 M urea, pH 8.0, and 
then resuspended in 5 M guanidine and 2 mM -mercaptoetha-
nol, pH 8.0. The solution was filtered (0.22 µm) and loaded onto 
an  affinity  chromatography  column  (HisTrap  HP;  GE  Health-
care), and the bound Cx26CL was washed with 100 mM imidazole 
and 5 M guanidine buffer, pH 8.0, before being eluted with 1 M 
imidazole and 5 M guanidine, pH 8.0, and dialyzed/precipitated 
against 20 mM MES, 50 mM NaCl, and 1 mM EDTA, pH 7.0. For 
NMR titration experiments, the Cx26CL was suspended in this 
buffer containing 6% LPPG. An intact purification tag and LPPG 
were necessary to maintain the solubility of the Cx26CL because 
of its preponderance of hydrophobic residues.
CT+CL peptide–binding assay
To assess interaction between Cx26CT and each of three 
biotCx26CL 
peptides, and any effect of taurine, Cx26CT peptide (50 ng/µl or 
100 ng/µl in 0.5× PBS at pH 6.5, 7.4, or 8.0; 100 µl) was adsorbed 
in individual wells of a 96-well Immulon-1B plate (Thermo Fisher 
Scientific) for 24 h at 4°C. BSA (1% wt/vol in 0.5× PBS at pH 6.5, 
7.4, or 8.0) was used as a control and also to block wells contain-
ing Cx26CT for a further 24 h at 4°C (200 µl). After block, plates 
were washed with 200 µl 0.5× PBS at pH 6.5, 7.4, or 8.0 containing 
0.05% vol/vol Tween 20 (PBST). PBST containing various con-
centrations of 
biotCx26CL synthetic peptides (up to 100 µM) were 
added to wells (pH 6.5, 7.4, or 8.0; 100 µl) for 3 h at 25°C in the 
presence and absence of taurine. After incubation, wells were 
washed (in PBST; pH and taurine concentration held constant), 
and 100 ng streptavidin–horseradish peroxidase (in PBST; pH 
and taurine concentration held constant) was added for 1 h. After 
further washing (in PBST; pH and taurine concentration held 
constant), the CT+CL interaction was assessed using an ELISA 
peroxidase substrate (200 µl; 1-step 2,29-azino-bis(3-ethylbenzthi-
azoline-6-sulfonic acid reagent [ABTS]; Thermo Fisher Scien-
tific)  incubated  at  room  temperature  for  30  min.  Absorbance 
(405 nm) in each well was measured with a plate reader (Victor3; 
PerkinElmer) and interpreted as the concentration of 
biotCx26CL 
noncovalently bound to Cx26CT.
NMR spectroscopy
NMR data were acquired on an NMR spectrometer (600 MHz; 
INOVA; Varian) using a cryoprobe. Interaction experiments   
between taurine and a 14–amino acid Cx26CT peptide were per-
formed at pH 6.5, 25°C, and in 0.5× PBS; Cx26CT was 4 mM and 
taurine was 30 mM (1:7.5 molar ratio), or 1 mM taurine and 3 mM 
Cx26CT (1:3 molar ratio). Interaction experiments between tau-
rine, Cx26CT, and Cx26CL were performed at pH 7.0, 42°C, in 
either 0.5× PBS or 20 mM MES, 50 mM NaCl, 1 mM EDTA, and 
6% wt/vol LPPG; titrations from the Cx26CT point of view were 
(Axiovert 100; Carl Zeiss). Hemichannel uptake was assayed by 
counting the number of cells receiving dye from the extracellular 
solution (Quist et al., 2000). The results of each experimental 
condition with taurine were normalized to its own control experi-
ment without taurine, which controls for differences in dye 
uptake  as  a  result  of  potential  differences  in  levels  of  plasma 
membrane hemichannel activity or levels.
“Parachute” assay for gap junctional communication
Semi-confluent “donor” and “receiver” cell populations were si-
multaneously induced for connexin expression by dox treatment 
for 48 h. The donor cells were then labeled with 10 µM CM-DiI 
(stock 10 mM in DMSO) and 5 µM calcein-AM (stock 5 mM in 
DMSO) for 30 min at 37°C. Donor cells were washed twice with 
0.1  M  PBS,  pH  7.4,  containing  0.3  mM  glucose,  trypsinized, 
seeded onto a semi-confluent monolayer of unlabeled receiver 
cells at an 1:150 donor/receiver ratio, and then allowed to at-
tach for 3 h at 37°C. Cells were examined and photographed 
under a photomicroscope (Axiovert 100; Carl Zeiss). Gap junc-
tion communication was assessed as the number of unlabeled 
cells receiving calcein (green) from each CM-DiI–labeled cell 
(red [+ green = yellow]). For each experimental condition, the 
average  number  of  receiver  cells  containing  dye  per  donor   
cell was determined and normalized to that of control cultures 
(Goldberg et al., 1995).
Molecular modeling
Molecular  models  of  taurine  and  different  Cx26-based  pep-
tides were made using Spartan 04 (Wavefunction, Inc.). Energy- 
minimized conformations were determined using MMFF94 force 
field rules (Halgren, 1996). If applicable, Hartree-Fock 6-31G* ab 
initio models (Hehre, 1973), subject to the MMFF-94 geometry 
constraints, were used for predicting molecular orbital structure 
(0.002 Å
3/atomic unit) and chemical behavior, allowing electro-
static potential and local ionization potential to be mapped onto 
orbital surfaces.
Peptide synthesis
Peptides corresponding to specific sequences of the CL domain 
of  rat  Cx26  (Cx26CL),  as  defined  by  the  UniProt  database 
(http://www.uniprot.org/uniprot/P21994) to be residues 99–139, 
were tested for their ability to interact with a peptide with sequence 
corresponding to the Cx26CT (residues 213–226). The Cx26CL 
was arbitrarily divided into overlapping peptide segments corre-
sponding to the first 20 amino acids of the CL nearest TM2 (CL1; 
residues 99–119), the last 20 amino acids of the CL nearest TM3 
(CL3; residues 120–139), and the middle 20 amino acids (CL2; 
residues 109–129; see Fig. 6 A). Peptides (>95% purity) were syn-
thesized  using  Fmoc  chemistry  with  an  automated  synthesizer 
(433; Applied Biosystems).
The  recent  crystal  structure  of  human  Cx26  (Maeda  et  al., 
2009) describes the CL as residues 98–129, whereas boundaries 
based on a combination of biochemical and hydrophobicity data 
are 97–132 (Nicholson, 2003; Sosinsky and Nicholson, 2005). The 
actual boundaries of functional, membrane-inserted channels re-
main uncertain. The rat and human Cx26 cytoplasmic domains 
are nearly identical in amino acid sequence.
Amino-terminal biotinylation of Cx26CL peptides (
biotCx26CL) 
was through amino-terminal linkage of activated Lys-biotin by Fmoc-
aminocaproic acid. Peptides were purified by C18 reverse-phase 
HPLC using a Dionex DX500 system and assessed by electrospray–
mass spectrometry using a Waters nano-liquid chromatography–
coupled electrospray ionization quadrupole-TOF-MS.
For  NMR,  a  peptide  corresponding  to  the  entire  Cx26CT 
(AnaSpec) was further purified using a C18 Sep-Pak cartridge 
(Waters) according to the manufacturer’s instructions to remove 
salt and/or trifluoroacetic acid, present as a result of the synthesis   Locke et al. 325
was tagged (Koreen et al., 2004; Locke et al., 2005). The 
epitope tag thus enabled recovery of homomeric Cx26T 
and Cx32T hemichannels and heteromeric Cx26T/Cx32 
and  Cx26/Cx32T  hemichannels.  Hemichannels  were 
reconstituted into unilamellar liposomes, and the effect 
of AS (10 mM of protonated taurine) was assessed in 
TSF gradients (Fig. 1).
Previous studies showed that homomeric Cx26 and 
heteromeric  Cx26/Cx32  hemichannels  from  native 
sources (i.e., untagged) were inhibited by protonated 
AS,  and  native  homomeric  Cx32  hemichannels  were 
taurine insensitive (Rhee et al., 1996; Bevans and Harris, 
1999; Locke et al., 2004b; Tao and Harris, 2004). Homo-
meric Cx32T hemichannels were also taurine insensi-
tive. Heteromeric hemichannels in which the Cx26 was 
untagged (Cx26/Cx32T) were inhibited by AS, as were 
the native Cx26/Cx32 hemichannels. In contrast, hemi-
channels in which the Cx26 was tagged, whether het-
eromeric Cx26T/Cx32 or homomeric Cx26T, were not 
AS sensitive (Fig. 1 A). These hemichannels were not 
inhibited  with  up  to  50  mM  of  protonated  taurine. 
Thus, the presence of the CT tag on Cx26, whether in 
homomeric or heteromeric hemichannels, blocked the 
AS inhibition.
The CT epitope tag is linked to the connexin by a 
thrombin cleavage site. To explore the role of the tag 
per  se  on  AS  sensitivity,  it  was  cleaved  with  thrombin   
before reconstitution. Tag cleavage (Tc) is not blunt, leaving 
four additional amino acids (LVPR; part of the thrombin 
recognition site) at the carboxyl terminus.
performed with 2 mM peptide in 0.5× PBS; titrations from the 
Cx26CL point of view were performed with 10 µM peptide in   
20 mM MES, 50 mM NaCl, and 1 mM EDTA containing 6% LPPG. 
Gradient-enhanced 2D 
1H-
13C HMQC and 2D 
1H-
15N HSQC were 
used to observe all natural carbon and nitrogen resonances.
R E S U LT S
Taurine effect on hemichannels is blocked by a purification 
tag on the Cx26CT
AS  (taurine)  effects  on  the  activity  of  hemichannels 
composed of Cx26 and/or Cx32 were assessed by TSF, a 
robust liposome-based assay for large molecule permea-
bility of channels (Harris et al., 1992; Rhee et al., 1996; 
Bevans et al., 1998; Bevans and Harris, 1999; Kim et al., 
1999, Bao et al., 2004; Locke et al., 2004a,b; Tao and 
Harris, 2004, 2007; Ayad et al., 2006). TSF fractionates 
liposomes  containing  channels  into  discrete  popula-
tions within an iso-osmolar density gradient, based on 
channel permeability to urea/sucrose. A change in lipo-
some distribution between the uppermost and lowest 
band positions, relative to control, is a measure of a 
change in the fraction of hemichannels permeable to 
the gradient solutes. Such a change can be due to com-
plete pore block or from reduction to near zero chan-
nel open probability.
Hemichannels were purified for functional study from 
HeLa cell lines stably transfected to inducibly express 
CT epitope–tagged Cx26 (Cx26T), Cx32 (Cx32T), or 
hemichannels  containing  both  connexins  where  one 
Figure 1.  Taurine inhibition involves the CT of Cx26. Hemichannel activity in liposomes is assessed as permeability to urea/sucrose by 
TSF. (A) Effect of the AS taurine on activity of carboxyl-terminal epitope-tagged (T) homomeric (Cx32T and Cx26T) and heteromeric 
(Cx26/Cx32T and Cx26T/Cx32) hemichannels. Only heteromeric hemichannels in which the Cx26CT is not tagged were AS sensitive; a 
tag on Cx26CT eliminated the AS sensitivity of homomeric Cx26T and heteromeric Cx26T /Cx32 hemichannels. Previous work showed 
that wild-type (untagged) Cx26-containing hemichannels were AS sensitive, and that homomeric Cx32 hemichannels were not (Bevans 
and Harris, 1999; Locke et al., 2004b; Tao and Harris, 2004). In this and subsequent TSF figures, the results for each experimental 
condition with taurine were normalized to its own control experiment without taurine (n = 6–9). (B) Effect of tag cleavage (Tc), which 
leaves four additional amino acids (LVPR) at the carboxyl terminus, on sensitivity to AS. Cleavage restores inhibition to heteromeric 
Cx26Tc/Cx32 hemichannels. AS sensitivity of all other hemichannel compositions was unaffected by tag cleavage. Surprisingly, the ac-
tivity of homomeric Cx26Tc hemichannels was unaffected by AS (n = 5–8). (C) AS narrows rather than closes Cx26Tc hemichannels. In 
TSF, liposome permeability to urea but not sucrose forms a band of intermediate density. (Left to right) TSF gradients with liposomes 
formed in the absence of connexin (showing upper band only), liposomes containing Cx26Tc hemichannels, and liposomes containing 
Cx26T hemichannels, all exposed to 10 mM AS. For Cx26Tc, the lower band density is shifted upwards compared with Cx26T hemichan-
nels. Therefore, AS narrows rather than closes Cx26Tc hemichannels but has no effect on activity in TSF (B) or permeation (C) of Cx26T 
hemichannels. None of the other channel compositions (tagged or tag-cleaved) was affected in this way by gradient AS. In A and B, the 
error bars are standard errors of the mean.326 Taurine gating of connexin26-containing channels
intermediate density in TSF gradients (Locke et al., 
2004a).  Elimination  of  permeability  to  molecules  as 
small as urea would effectively eliminate the ability   
of connexin channels to mediate molecular signaling   
in vivo.
To assess this possibility for Cx26T and Cx26Tc chan-
nels, densities of liposome bands were measured after 
TSF centrifugation. In taurine, the lower band of Cx26T 
liposomes was at the same density as that of Cx26Tc 
liposomes not exposed to taurine, indicating hemi-
channel permeability to both urea and sucrose. In con-
trast, in taurine the lower band of Cx26Tc liposomes was 
at a less dense, intermediate position, indicating perme-
ability of Cx26Tc hemichannels to urea but not sucrose. 
Therefore, AS narrows rather than closes Cx26Tc hemi-
channels (Fig. 1 C) and has no discernable effect on the 
pore diameter of Cx26T hemichannels. Taurine-exposed 
liposomes  containing  tagged  and  tag-cleaved  hetero-
meric Cx26/Cx32 and homomeric Cx32 hemichan-
nels (Cx26T>Tc/Cx32, Cx26/Cx32T>Tc, and Cx32T>Tc) do 
not form intermediate bands that indicate hemichan-
nel narrowing; with AS treatment, liposomes contain-
ing untagged heteromeric Cx26/Cx32 hemichannels 
and  homomeric  Cx26  hemichannels  change  their 
distribution from the lowest band to the upper band, 
AS inhibition was restored in tag-cleaved heteromeric 
hemichannels (Cx26Tc/Cx32), but, surprisingly, homo-
meric  Cx26Tc  hemichannels  remained  AS  insensitive 
(Fig. 1 B). Not surprisingly, the Cx32Tc hemichannels 
were AS insensitive (see below), and Cx26/Cx32Tc hemi-
channels were AS sensitive. Therefore, for heteromeric 
channels, the presence of the intact CT epitope tag but 
not  the  extra  four  amino  acids  that  remain  after  tag 
cleavage interfered with AS inhibition, confirming the 
role of the CT tag in AS insensitivity and suggesting that 
the CT is involved in processes that occlude the Cx26 
permeability pathway. However, in the homomeric Cx26Tc 
hemichannels, the presence of the four additional amino 
acids was sufficient to block the AS effect on hemichan-
nel activity.
Taurine narrows Cx26Tc pores
TSF reports hemichannel activity as assessed by perme-
ability to urea and sucrose (see Materials and methods). 
However, it is also possible that an applied compound 
restricts the pore diameter so that it is permeable only 
to the smaller molecule (i.e., urea, 3.6-Å diameter) 
and impermeable to the larger molecule (i.e., sucrose, 
4.5-Å  diameter).  In  this  case,  liposomes  undergo 
osmotically driven shrinkage that results in a band of 
Figure  2.  Cx26CT  domain  is 
involved in inhibition by taurine. 
The protonated amine of the AS 
is involved in connexin binding, 
and the ionized sulfonate moiety 
is involved in effecting the inhi-
bition  (Tao  and  Harris,  2004). 
(A) Side view of taurine showing 
the  energy-minimized  confor-
mation  determined  using  the 
MMFF94 force field rule. Black, 
carbon; red, oxygen; gray, nitro-
gen; blue, sulfur. (Below) Its mo-
lecular  orbital  structure  (0.002 
Å
3/atomic  unit;  transparency) 
determined  by  Hartree–Fock 
6–31G*  ab  initio  models,  sub-
ject to MMFF94 equilibrium ge-
ometry  constraints;  electrostatic 
potential  (red,  negative;  blue, 
positive)  and  local  ionization 
potential  (red,  ionized;  blue, 
nucleophile) were mapped onto 
this orbital surface. (B) Energy- 
minimized conformations, in scale 
with A, of wild-type (nontagged) 
Cx26CT  (left)  and  Cx26Tc  CT 
(right), as determined using the 
MMFF94  force  field  rule.  Note 
two  surface  side-facing  acidic   
lysine residues (K231 and K233), 
which may interact with the sul-
fonate group of taurine and/or 
be involved in pore occlusion.  Locke et al. 327
The  molecular  permeability  and  AS  sensitivity  of 
Cx26 and/or Cx32 hemichannels was assessed by up-
take  of  an  extracellular  membrane–impermeant  dye, 
calcein, in low [Ca
2+]ex with and without induction of 
connexin expression (see Materials and methods; Koreen 
et al., 2004) (Fig. 3). Calcein loading into uninduced 
cells was minimal (Fig. 3 A, top). When connexin ex-
pression  was  induced,  almost  all  cells  were  loaded 
(Fig. 3 A, bottom). Under both conditions, uptake in the 
presence of high [Ca
2+]ex was minimal, comparable to 
that without connexin induction.
Cytoplasmic taurine levels in HeLa cells can be modu-
lated via extracellular taurine, which enters via an endog-
enous taurine transporter (Ramamoorthy et al., 1994). 
Extracellular taurine also may enter cells though non-
junctional hemichannels opened by low [Ca
2+]ex. Tau-
rine modulation of low [Ca
2+]ex calcein uptake by cells 
expressing the different tagged connexin hemichannels 
was assessed. Uptake without induction of connexin 
expression  was  subtracted  from  that  with  induction, 
and the results normalized to uptake in the absence of 
taurine. Dye uptake was taurine sensitive only in cells 
expressing heteromeric hemichannels in which the Cx26 
was untagged (Cx26/Cx32T, not Cx26T/Cx32) (Fig. 3 B). 
Dye uptake by these cells in the presence of taurine was 
markedly reduced compared with cells not exposed to 
taurine and compared with the absence of effect of 
taurine on uptake by the other cells under the same   
conditions. Thus, the taurine sensitivity of the various 
hemichannels  expressed  in  cells  corresponds  to  that 
seen  with  purified  liposome-reconstituted  hemichan-
nels in the TSF system. The inhibition of dye uptake was 
not complete, which is likely to be due to differences   
in the cellular uptake of extracellular taurine and the   
intracellular levels achieved.
not to an intermediate band, indicating full occlusion of 
the hemichannels.
Thus, there is an effect of AS on pore diameter only in 
homomeric Cx26 hemichannels with four extra amino 
acids at the carboxyl terminus. It is tempting to suggest 
that this AS-induced effect of a truncated tag on Cx26 is 
a  partial  form  of  the  same  molecular  mechanism  by 
which an untagged CT causes full occlusion of the pore 
in the presence of AS.
Subtle conformational differences between native Cx26 
CT and Cx26Tc CT
TSF hemichannel studies implicate the Cx26CT in the 
AS  effect  on  heteromeric  Cx26-containing  channels 
and in the AS-mediated narrowing of Cx26Tc hemichan-
nels. An energy-minimized conformation for nontagged 
Cx26 CT and length-modified Cx26Tc CT was calculated 
using MMFF94 force field molecular mechanics (Halgren, 
1996) (Fig. 2 B). In energy-minimized conformations, 
the Cx26Tc CT is 5 Å longer than the nontagged (wild-
type) Cx26 CT, but of similar width (K231–K233 dis-
tance measured in Fig. 2 B). If the CT acts by physically 
occluding the Cx26 pore, the difference in dimension 
of Cx26Tc CT could produce only partial or imperfect 
occlusion of the permeability pathway, resulting in per-
meability to urea but not sucrose, as observed in TSF.
Taurine affects hemichannel function in cells
The presence of nonjunctional hemichannels in plasma 
membrane is well supported (Contreras et al., 2003; Sáez 
et al., 2005; Srinivas et al., 2006). Hemichannels activate 
in low [Ca
2+]ex (e.g., 0.5 mM), providing a selective path-
way for uptake of extracellular molecule(s) (Koreen et al., 
2004) and/or release of cytoplasmic molecules (e.g., ATP, 
prostaglandin; Harris, 2007; Schalper et al., 2009).
Figure 3.  Taurine inhibits cellular hemi-
channel function. Calcein uptake by cells 
expressing  connexin  hemichannels  was 
assessed by incubation with extracellular 
calcein  in  low  Ca
2+  medium  (Goldberg 
et al., 1995; Li et al., 1996). (A) Dye up-
take correlated with doxycycline-induced 
expression  of  connexin  (Cx32T  in  this 
illustration). Similar induction of dye up-
take  was  observed  for  all  cell  lines  used 
(n = 3). (B) Effects of extracellular AS on 
dye uptake by cells expressing the various 
connexin channels (extracellular taurine 
enters  cells  via  a  taurine  transporter; 
Ramamoorthy et al., 1994) (n = 3). Only 
channels in which the Cx26 subunits are   
not tagged were AS sensitive, corresponding   
to the results from the liposome-based TSF 
study (Fig. 1). The results for each experi-
mental  condition  with  taurine  were  nor-
malized  to  its  own  control  experiment   
without taurine. Error bars are standard   
errors of the mean.328 Taurine gating of connexin26-containing channels
HEPES, a membrane-impermeant AS, was used to block 
cytoplasmic taurine uptake via its plasma membrane trans-
porter (Petegnief et al., 1995). In the presence of extra-
cellular  HEPES,  Cx26/Cx32T-junctional  channels  were 
AS insensitive in the presence of extracellular taurine 
(Fig. 4 A, arrow). Under these conditions of normal 
[Ca
2+]ex, nonjunctional hemichannels are closed, so pos-
sible taurine influx through this pathway would be dra-
matically reduced. This result also shows that the taurine 
effect requires AS import into the cell, confirming the 
cytoplasmic location of its site of action, as suggested by 
the effects of the CT epitope tag.
Taurine closes nontagged Cx26 hemichannels  
and junctional channels
AFM and TSF studies have shown that purified non-
tagged homomeric Cx26 hemichannels close in response 
to acidification, but only in the presence of a protonated 
AS buffer (Locke et al., 2004b; Tao and Harris, 2004).
To directly assess AS sensitivity of nontagged Cx26 
hemichannels and junctional channels in native mem-
branes, cellular studies were performed using the HeLa 
cell line used for the previous AFM studies (Hand et al., 
2002; Yu et al., 2007). The addition of taurine markedly 
reduced nontagged Cx26 hemichannel calcein uptake 
and junctional cell–cell passage of calcein, compared 
with the same cell lines without exposure to taurine 
(Fig. 4, B and C). Extracellular HEPES restored AS in-
sensitivity to the nontagged Cx26-junctional channels 
in the presence of taurine (Fig. 4 C, arrow).
Collectively, these data make clear that AS modulates 
hemichannels  and  junctional  channels  that  contain 
Taurine affects junctional channel function
The question arises as to whether taurine modulates   
the  function  of  junctional  channels  in  a  manner   
similar to its effects on hemichannels. It is possible 
that  the  taurine-binding/effector  site  is  inaccessible 
when hemichannels dock to form a junctional chan-
nel,  or  that  the  junctional  structure  itself  does  not   
permit the changes in pore structure that alter molec-
ular permeability.
Gap  junctions  are  permeable  to  large  molecular 
weight dyes, used as indicators of junctional channel 
function (Weber et al., 2004). In our experiments, a   
donor–receiver parachute coupling assay was used to 
reveal changes to intercellular dye permeability in the 
presence of extracellular taurine. In brief, dye donor 
and  receiver  cells  were  preinduced  for  connexin  ex-
pression. After induction, donor cell membranes were 
fluorescently labeled, and the cells were loaded with the 
junction permeable dye calcein (via its AM-ester). After 
removal  of  extracellular  calcein-AM,  donors  were 
seeded onto a receiver cell monolayer, which was evalu-
ated for calcein transfer from loaded to unloaded cells 
(Goldberg et al., 1995).
Intercellular dye transfer in taurine-exposed Cx32T 
cells  was  unchanged  compared  with  controls,  as  ex-
pected. Intercellular calcein transfer in taurine-exposed 
Cx26-expressing cells was decreased only in the Cx26/
Cx32T  cells  and  not  in  the  Cx26T/Cx32  cells  or  the 
Cx26T cells, compared with the same cells without tau-
rine (Fig. 4 A). These results correspond to those seen 
in  the  studies  of  hemichannel  liposomes  and  native 
membranes, above.
Figure 4.  Taurine inhibition of gap-junctional channels and involvement of the CT. Intercellular spread of calcein was assessed by a 
“parachute” assay in which calcein-loaded donor cells were seeded onto a monolayer of receiver cells (Goldberg et al., 1995). (A) Only 
junctional channels in which the Cx26 subunits were not tagged were inhibited by extracellular AS, consistent with the hemichannel 
data (Figs. 1 and 3). A membrane-impermeant AS, HEPES, was used to block taurine transport into the cells (Petegnief et al., 1995). 
HEPES effectively eliminated the taurine effect on Cx26/Cx32T junctional channel permeability of calcein (n = 4–9). (B) AS blocks 
wild-type (nontagged) Cx26 hemichannels. Hemichannel uptake of extracellular calcein was assessed as in Fig. 3. In contrast to the 
AS insensitivity of Cx26T and Cx26Tc hemichannel function, nontagged Cx26 hemichannels were AS sensitive, as had been shown for 
preparations of purified hemichannels (Locke et al., 2004b; Yu et al., 2007), but not previously in a cellular context (n = 3). (C) AS 
substantially reduced intercellular calcein dye transfer through junctional channels composed of untagged Cx26, in contrast to no   
effect on Cx26T junctional channels (see A; n = 4–9). The effect on nontagged Cx26-junctional channels was also eliminated by HEPES. 
The results for each experimental condition with taurine were normalized to its own control experiment without taurine. Error bars are 
standard errors of the mean.  Locke et al. 329
perhaps in a ternary complex, or that taurine competes 
with CT for a binding site on another connexin domain. 
An intramolecular complex involving the CT and CL 
domains  of  Cx26  had  been  postulated  from  previous 
work, based on superficial sequence homologies with 
taurine-binding sites of pentameric ligand–gated ion chan-
nels (Bevans and Harris, 1999; Tao and Harris, 2004).   
In addition, in other connexins there is interaction of 
CT and CL domains; pH gating of Cx43 channels in-
volves interaction of the Cx43CT (“ball”) with a “recep-
tor” domain in its CL (Cx43CL; Homma et al., 1998) 
(however, the Cx43CT is significantly longer than the 
Cx26CT, and the Cx26CT does not contain the sequences 
of the Cx43CT that its pH sensitivity requires).
The possibility of binary or ternary interactions among 
AS, Cx26CT, and Cx26CL was first assessed by pep-
tide ELISA. Specifically, ELISA was used to test whether 
the Cx26CT peptide binds to the Cx26CL, to which re-
gions, and whether this occurs in an AS-dependent or 
AS-independent  manner.  ELISA  plates  coated  with 
Cx26CT peptide at 50 or 100 ng/µl were probed with 
each of three biotinylated Cx26CL (
biotCx26) peptides 
at pH 6.5, 7.4, and 8.0. These CL peptides match the 
first 20 amino acids of the Cx26CL nearest the sec-
ond transmembrane domain (TM2) (
biotCL1), the last 
20 amino acids nearest the third transmembrane do-
main (TM3) (
biotCL3), or the middle 20 amino acids 
(
biotCL2) (Fig. 6 A).
The data show significant interaction only between 
the Cx26CT peptide and 
biotCL3, a peptide correspond-
ing to the CT-proximal region of the Cx26CL, residues 
120–139.  The  Cx26CT–
biotCL3  interaction  increases 
with acidic pH. Furthermore, this interaction is substan-
tially reduced by 10 mM taurine (Fig. 6 A; rightmost bar 
of each triplet). 
biotCL1 and 
biotCL2 did not bind immo-
bilized Cx26CT at any of the pHs tested.
Cx26, and that the modulation critically involves the CT 
of Cx26, and does not involve Cx32.
Taurine does not bind Cx26CT
The Cx26CT domain contains no acidic residues, that 
is, residues that could interact electrostatically with the 
amine group of AS, except for the carboxyl terminus 
itself. However, the Cx26CT contains several basic resi-
dues that could interact with the sulfonate moiety of AS. 
An electron density model of taurine (i.e., van der Waal 
surface  of  its  energy-minimized  structure)  was  calcu-
lated using the ab initio Hartree–Fock self-consistent 
field method (Hehre, 1973), allowing electrostatic po-
tential  and  local  ionization  potential  to  be  mapped 
onto its orbital surface (Fig. 2 A). In energy-minimized   
conformations, there are two surface side-positioned, 
outward-facing  basic  lysine  residues  (positions  K231 
and K233) in Cx26CT and Cx26Tc CT structures that 
could interact with the taurine sulfonate group (Fig. 2 B, 
in red on taurine potential surfaces).
The potential binding of AS to Cx26CT was explored 
by  NMR.  The 
13C-HMQC  spectrum  obtained  from  a 
14-residue peptide corresponding to the Cx26CT was 
overlayed with a spectrum from the same peptide in the 
presence  of  taurine  (Fig.  5  A).  Also,  the 
13C-HMQC 
spectrum from taurine was overlayed with that observed 
in the presence of the peptide (Fig. 5 B). In both cases, 
the centroids of the resonances were identical, indicat-
ing  that  taurine  does  not  structurally  interact  with  a 
peptide corresponding to the entire CT of Cx26.
pH-dependent intramolecular binding involving Cx26CT 
and Cx26CL is modified by taurine
The clear involvement of the Cx26CT and the absence 
of a binary interaction with taurine suggest that the CT 
and/or taurine interact with another connexin domain, 
Figure 5. 
13C-HMQC NMR demonstrating the Cx26 CT 14mer does not complex with taurine. (A) The spectrum of the Cx26CT alone 
(black) is overlaid with its spectrum in excess taurine (red) at a 1:7.5 molar ratio. The two overlays (left vs. right) differ in the proton 
region selected for observation. (B) Close-up of a spectrum of each of the two methyl (-CH2-) groups of taurine (black) overlaid with the 
same spectrum of taurine in excess Cx26CT (red) at a 1:3 molar ratio. (Left) The methyl group closest to the sulfonate moiety (-SO3H). 
(Right) The methyl group closest to the amine (-NH2). In both cases, the resonance centers do not change, which further indicates lack 
of interaction between taurine and the Cx26CT peptide.330 Taurine gating of connexin26-containing channels
greater at lower pH, consistent with Fig. 6 A. The dis-
sociation constants are in the low micromolar range 
at pH 7.4. No difference in Kd was seen for the two 
concentrations of Cx26CT peptide used as bait (data 
in Fig. 6 B are pooled from 50- and 100-ng/µl experi-
ments), also consistent with a first-order interaction. 
These data make clear that, for Cx26, acidic pH in the 
physiological range enhances interaction between its 
CT and a specific segment of the CL nearest TM3.   
Concentration  dependence  curves  derived  from 
the ELISA data for the Cx26CT–
biotCL3 interaction at 
pH 6.5 and 7.4 are shown in Fig. 6 B. The monoexpo-
nential increase in the amplitude of the binding to 
Cx26CT as a function of 
biotCL3 concentration sug-
gests that this interaction is described by first-order 
kinetics, and accordingly, the apparent Kds could be 
determined at each pH. The data show that the apparent   
affinity  of  the 
biotCL3  peptide  for  the  Cx26CT  was 
Figure 6.  pH-dependent binding of Cx26CT to Cx26CL is modified by taurine. Interaction between the CT peptide and peptides 
based on the CL domain at different pHs, and the effect of taurine (absence [] or presence [+]) on the interaction was assessed by 
a modified ELISA technique. A peptide corresponding to the entire Cx26CT was immobilized and used as bait. (A) pH-dependant 
interaction between Cx26CT and the second half of the Cx26CL (CL3) occurred at acidic pH and was largely reversed by taurine. 
In contrast, CL2 (peptide corresponding to the middle 20 amino acids of the Cx26CL) showed no significant interaction with the 
CT peptide, and although CL1 (peptide corresponding to the first 20 amino acids of the Cx26CL) showed some interaction at acidic 
low pH, this was unaffected by taurine. (Bottom) Schematic of the nonmembrane residues of rat Cx26, the positions of the three 
biotCx26CL peptides used for the ELISA, and homology comparisons (black, neutral; red, negative; blue, positive) between 
biotCL3 
and the corresponding segments in rat Cx32 and human Cx43. The CL-TM3 boundary of human Cx26 as shown by crystallography 
(Maeda et al., 2009) is identified by apposing arrows. The helical wheel representation of CL3 indicates an amphipathic character, 
with a strongly hydrophobic stripe (I, L, I), if it is  helical (the CL was unresolved in the crystal structure). (B) Fractional binding 
is plotted against the concentration of 
biotCx26CL residues 120–139 (CL3) at pH 6.5 (filled squares) and pH 7.4 (open circles). Dis-
sociation constants (Kds) were determined from single-exponential fits to the data. (C) Fractional binding is plotted as a function 
of the log taurine concentration at pH 6.5 (filled squares) and pH 7.4 (open circles). Binding at 0 mM taurine is normalized to 
unity for each pH condition. Each data point is the mean of three independent experiments at 50 and 100 ng/µl of immobilized 
Cx26CT bait. In A and C, CL peptide concentration was 10 µM. In A, taurine concentration was 10 mM, and filled bars are nonspe-
cific interaction with BSA. No significant binding of any 
biotCx26CL peptide was detected when BSA (1% wt/vol) was used as bait 
or ligand, when 
biotCx26CL was added to uncoated plates, or plates were coated with 1% wt/vol BSA. Error bars are standard errors 
of the mean.  Locke et al. 331
Taurine and Cx26 CT interact at some of the same sites  
on Cx26CL
The  ELISA  results  suggested  further  NMR  structural 
characterization of the Cx26CT and Cx26CL interac-
tions,  in  the  presence  and  absence  of  taurine.  NMR 
spectra of the entire Cx26CL (10 µM) labeled with [
15N]H4 
reveal interactions with taurine (30 mM) (Fig. 7 A) and 
the Cx26CT peptide (4 mM) (Fig. 7 B) at pH 7.0. The 
main resonance spectra show that both taurine and 
the Cx26CT affect many Cx26CL resonance peaks, but 
that more resonance peaks are affected by the Cx26CT 
than by taurine; for example, in Fig. 7, more resonance 
peaks show displacement of the red (with taurine or 
Cx26CT) from the black (control) spectra. Close-ups of 
individual resonance peaks in Fig. 7 show that taurine 
interacts with the Cx26CL at some residues (peaks iii 
and iv), but not at others at which the Cx26CT does 
(peaks v and vi). There are other resonance peaks at 
which there is no effect by either taurine or the Cx26CT 
(Fig. 7, peaks i and ii).
These  NMR  data  confirm  interaction  between  the 
Cx26CT and Cx26CL. They also indicate that an inter-
action site for taurine exists in the Cx26CL (as opposed 
Intramolecular interactions have not been shown pre-
viously for Cx26.
The  inhibitory  effect  of  taurine  on  this  pH-driven   
interaction is demonstrated in Fig. 6 C, which shows the 
effect of increasing taurine concentration on the inter-
action between the Cx26CT “bait” and a concentration 
of 
biotCL3 near its Kds (10 µM; 6.26 ng/µl) at pH 6.5 and 
7.4. Disruption of the interaction between the CL and 
CT peptides was a linear function of the log of taurine 
concentration over the range shown, and was substan-
tially greater at the lower pH (i.e., the relation has a 
steeper slope). Approximately 50% of the CL–CT pep-
tide interaction is disrupted at 1 mM taurine at pH 6.5. 
At taurine concentrations beyond 1 mM, the trend con-
tinued, with complete dissociation by 5 mM, but the 
relations could not be fit to any standard binding iso-
therm, suggesting pleiotropic effects on the peptide 
structure/interactions at these concentrations that could 
not be mechanistically characterized.
Collectively,  these  binding  studies  demonstrate  a 
specificity of Cx26CT–
biotCL3 interactions, with acidic 
pH both enhancing the interaction as well as the ability 
of taurine to disrupt it.
Figure 7. 
1H-
15N HSQC demonstrating that Cx26CL in-
teracts with both taurine and the Cx26CT. Pairwise inter-
actions between CL peptide and taurine or CL peptide 
were reassessed by NMR. Control spectrum of the [
15N]-
labeled Cx26CL (10 µM; black) overlaid with spectra of the 
Cx26CL in the presence of (A) 30 mM taurine (red) or 
(B) 4 mM Cx26CT peptide (red). (Right) Close-up view of 
representative resonance peaks of the Cx26CL that were 
unaffected (i and ii) and affected (iii–vi) by the presence of 
these ligands. Resonance peaks iii and iv were affected by 
taurine, but resonance peaks v and vi were not, whereas res-
onance peaks iii–vi were affected by the Cx26CT peptide.332 Taurine gating of connexin26-containing channels
but not necessarily complete scenario that emerges is 
that taurine can directly displace the CT from sites on 
the CL by binding at those CL sites; thus, taurine is a 
competitive inhibitor of the interaction between Cx26CT 
and the Cx26CL.
to the Cx26CT; Fig. 5), and that taurine affects only a 
subset of the Cx26CL residues that interact with the 
Cx26CT. This latter finding suggests that some sites of 
Cx26CT and taurine interaction with the Cx26CL over-
lap, providing a rationale for the disruption of the 
CL–CT interaction by taurine seen by ELISA.
The resonance spectra in Fig. 8 show the effect of tau-
rine on Cx26CL–Cx26CT interactions as reported by 
changes  in  the  resonances  of  [
15N]-labeled  Cx26CL. 
First, there are residues (resonance peaks) in Cx26CL 
that  are  unaffected  by  interaction  with  the  Cx26CT, 
both in the presence and absence of taurine, as indi-
cated in Fig. 8 A by the absence of centroid displacement 
of  the  contours  for  Cx26CL  alone  (black),  Cx26CL+ 
taurine (red), Cx26CL+Cx26CT (blue), and Cx26CL+ 
Cx26CT+taurine  (green).  Other  resonance  peaks  in 
the Cx26CL are affected by the Cx26CT (displacement 
of black and blue contours) and unaffected by taurine 
(no displacement of red from black, or green from blue 
contours; Fig. 8 B).
Significantly, some Cx26CL residues affected by the 
Cx26CT (displacement of blue from red contours in 
Fig. 8 C) return back toward their Cx26CT-unbound 
state  in  the  presence  of  taurine  (superimposition  of 
black and green contours), indicating that taurine re-
verses the Cx26CL–Cx26CT interaction at this position. 
At the same resonances, the addition of taurine alone 
affects the Cx26CL (displacement of red from black in 
Fig. 8 C), suggesting direct taurine interactions with the 
Cx26CL at the same sites (a binary interaction).
Thus,  an  interaction  site  for  taurine  exists  in  the 
Cx26CL, and taurine affects a subset of the Cx26CL res-
idues  that  also  can  interact  with  the  Cx26CT.  Lastly, 
there are resonance peaks in the NMR spectra affected 
independently by taurine and by the Cx26CT, which 
move to unique positions in the presence of both tau-
rine and the Cx26CT (Fig. 8 D). This could suggest that 
taurine  interacts  at  unique  sites  generated  by  the 
Cx26CL–Cx26CT  complex  (a  ternary  interaction)  or 
that the site has not been sufficiently saturated with tau-
rine to disrupt the Cx26CL–Cx26CT complex so the 
observed changes in peak resonance result from a mix-
ture of reversed and nonreversed Cx26CL–Cx26CT inter-
actions (a mixture of binary interactions involving this 
site).
Collectively, these NMR data show direct binary inter-
action of taurine with the Cx26CL and direct binary   
interaction of the Cx26CT with the Cx26CL. They also 
show that some Cx26CL sites affected by taurine are 
also affected by Cx26CT. The addition of taurine can 
completely reverse the effect of Cx26CT binding at some 
sites, and at other sites may form a ternary complex under 
these conditions. At sites where taurine does not inter-
act with the Cx26CL, it has no effect on the Cx26CL–
Cx26CT interaction; only where taurine interacts with the 
CL does it have an effect on CT–CL interactions. A simple 
Figure  8. 
1H-
15N  HSQC  demonstrating  that  the  Cx26  CT–CL 
complex is affected by taurine. Interactions among CT peptide, 
CL peptide, and taurine were further assessed by NMR. All pan-
els display individual Cx26CL resonance peaks. In each spectra, 
contours are colored as follows: black, [
15N]-labeled Cx26CL; red, 
[
15N]-labeled Cx26CL plus taurine; blue, [
15N]-labeled Cx26CL 
plus unlabeled Cx26CT; green, [
15N]-labeled Cx26CL plus un-
labeled Cx26CT plus taurine. Concentrations are as follows: 10 µM 
Cx26CL, 4 mM Cx26CT, and 30 mM taurine. (A) Resonance peaks   
of  Cx26CL  that  are  unaffected  by  taurine,  by  Cx26CT,  or  by   
both taurine and Cx26CT. (B) Resonance peaks of Cx26CL show-
ing no effect of taurine (black and red overlap), an effect of the 
Cx26CT (blue displaced from black), and a negligible effect of 
taurine on the Cx26CL–Cx26CT complex (green superimposed 
on blue). (C) Resonance peaks demonstrating an effect of tau-
rine on Cx26CL (displacement from red from black), an effect of 
Cx26CT on Cx26CL (displacement of blue from black), and, in-
triguingly, displacement of the Cx26CL–Cx26CT complex by tau-
rine (green moves away from blue toward black). (D) Resonance 
peaks showing a site in Cx26CL that is affected differently by each 
of the conditions (none of the spectra overlap).  Locke et al. 333
detectible  interaction  of  taurine  with  a  peptide  corre-
sponding to the full-length CT (Fig. 5), but that there was 
interaction between the full-length CL and taurine. Fur-
thermore, the NMR studies revealed interactions between 
the CL peptide and the CT peptide, and that taurine   
interfered with this interaction (Figs. 7 and 8). These data 
identify AS as a modulator of CL–CT interactions. The 
specificity and characteristics of these interactions were 
explored by ELISA, which showed that the CT interacted 
only with the second half of the CL, this interaction was 
favored by low pH, and taurine disrupted it by competi-
tive interaction (Fig. 6).
As mentioned, previous work showed that the proton-
ated amine of AS is a key element of binding to connexin, 
and that the sulfonate moiety is involved in the functional 
effect (Tao and Harris, 2004). The first half of the CL3 
peptide (rat Cx26, residues 120–129) contains a mixture 
of positive and negative charged residues, providing op-
portunity for interaction with both charged moieties of 
taurine (Fig. 6 A). The pH- or AS-dependent gating of 
human Cx26 channels that have mutations in this seg-
ment  have  not  been  reported,  although  mutations  at 
K122 or R127, or deletion of E120, are reported to cause 
nonsyndromic deafness in humans (Green et al., 1999; 
D’Andrea et al., 2002; Palmada et al., 2006; Mani et al., 
2009). Mutation at the latter two sites yields channels that 
insert  in  plasma  membrane  but  do  not  mediate  junc-
tional coupling.
The recent crystal structure of human Cx26 (Maeda   
et al., 2009) shows the CL/TM3 (third transmembrane 
domain) boundary at residue 129, whereas biochemical/
hydrophobicity data show it at residue 132 (Nicholson, 
2003).  The  actual  boundary  in  functional  membrane- 
inserted channels remains uncertain, but in either case, 
the region of charged residues that potentially interact 
with  the  Cx26CT  and/or  AS  in  the  first  half  of  the 
Cx26CL3 peptide would be that immediately proximal to 
TM3, a region perhaps close to the Cx26CT (the crystal 
structure did not resolve the CL or the CT).
Comparison of the corresponding sequence in the   
AS-insensitive  connexin  Cx32  shows  that  the  Cx32  se-
quence lacks an acidic residue at position 128 (Cx26-E128 
vs. Cx32-S128), which is very close to the hydrophobic sec-
ond half of the sequence, which is proximal to TM3, and 
immediately follows a highly basic segment (Fig. 6 A). It is 
tempting to speculate that because AS action requires 
close coordination with both a basic and an acidic resi-
due, the absence of the acidic residue at position 128 pre-
vents an AS effect on Cx32 channels.
CL–CT interactions
NMR and the ELISA studies together make two impor-
tant points about CL–CT interactions in Cx26: (1) there 
is an interaction, and (2) it is favored by mildly acidic 
pH. This is the first evidence for interdomain modula-
tory interactions in Cx26. Interaction between the CL 
D I S C U S S I O N
Previous work showed that protonated AS act directly 
on channels that contain Cx26 to inhibit their permea-
bility. The present work shows that the AS effects re-
quire an unmodified CT and explores the mechanism 
of AS inhibition using wild-type Cx26 and Cx26 with 
amino acid additions to the carboxyl terminus, when 
expressed as homomeric channels and as heteromeric 
channels with wild-type Cx32 and with Cx32 with amino 
acid additions to its carboxyl terminus.
The AS-mediated inhibition was studied using hemi-
channels  reconstituted  into  liposomes,  hemichannels 
in plasma membranes of cells, and junctional chan-
nels between cells. The results were consistent across 
all three systems, showing that the CT of Cx26 is a   
critical component of AS sensitivity and that the effect 
occurs only when AS has access to the cytoplasmic aspect 
of the channels.
ELISA and NMR studies showed that AS does not in-
teract with the isolated Cx26CT, but rather that the CT 
can interact directly with the proximal segment of the 
complex, more so at acidic pH, and that AS interacts 
with the complex to disrupt this interaction, which cor-
relates with inhibition of channel function. These find-
ings are interpreted in the contexts of the molecular 
and  intramolecular  interactions  involved  and  of  the 
proposed gating mechanisms of connexin channels.
Involvement of the Cx26CT
The  liposome  data  show  that  for  homomeric  Cx26 
channels, an unmodified CT is required for AS-mediated 
inhibition, which does not require other soluble/cyto-
plasmic factors or involvement of other connexins. The 
addition of four extra amino acids to the CT (Cx26Tc) 
converts the effect of AS from pore occlusion to pore 
narrowing,  whereas  a  longer  (28–amino  acid)  exten-
sion to the CT (Cx26T) eliminates the AS effect com-
pletely. These results suggest that the CT is a crucial 
component of AS-mediated effects of Cx26 on channel 
function, and that AS itself does not occlude the pore. 
This is the first evidence that the short Cx26CT influ-
ences channel function.
Thus, all indications are that the CT of Cx26 itself is 
directly involved in the subsequent AS channel inhibi-
tion. It follows that the Cx26CT could be the locus of AS 
binding and/or be structurally involved in channel gat-
ing. The narrowing of the channel in response to AS 
when there is a minor length alteration (LVPR sequence 
at the carboxyl terminus; Cx26Tc) suggests direct involve-
ment of the CT in Cx26 pore occlusion.
AS–CL interactions
In theory, the AS-binding site could be within the Cx26CT, 
or elsewhere with allosteric involvement of the CT. NMR 
studies answered this question, showing that there was no 334 Taurine gating of connexin26-containing channels
corresponding to the second half of the Cx26CL, prox-
imal to TM3, which increases with pH change from 8.0 
to 6.5. Although the peptides differ and the conditions 
are necessarily quite different, both types of experiments 
show interactions at corresponding pHs.
The NMR spectra in Fig. 8 indicate a variety of inter-
actions at different sites in the Cx26CL. Specifically, the 
spectra in Fig. 8 C show complete reversal by AS of the 
effect of the CT on CL peak resonances, as expected for 
complete dissociation of the CT from the CL. However, 
the spectra in Fig. 8 B show no effect of AS at a site 
(resonance peak) where the CT has an effect, suggest-
ing that the CL–CT interaction persisted. The spectra 
in Fig. 8 D show an intermediate condition, in which AS 
had an effect on the CT-induced shift but did not re-
verse it. The latter two categories indicate that in the 
conditions under which the spectra were obtained ei-
ther (a) there was a ternary complex between all three 
elements, or (b) the displacement of the CT from the CL 
was incomplete. The ELISA data in Fig. 6 A indicate 
substantial but not complete dissociation of the CT pep-
tide from the 
biotCL3 peptide at high taurine concentra-
tion, which could account for the heterogeneity in the 
NMR spectra. It could also indicate that AS interaction 
with the CL is positively modulated by formation of the 
CL–CT complex. The precise structural mechanism of 
AS-induced CT–CL dissociation remains unclear. Never-
theless, given that the dominant effect of AS is to both 
decrease the CL–CT interaction and increase the im-
permeability of the channels, we attribute the latter to 
the former, favoring a binary AS–CL interaction rather 
than a stable ternary AS–CL–CT interaction as respon-
sible for the functional effect.
We also note the substantial differences in the condi-
tions and peptides required for the two types of experi-
ments of modular interaction. The NMR studies were 
performed in free solution with a His-tagged full-length 
CL peptide and the CT peptide, in 6% LPPG and pH 
7.0 at 42°C (see Materials and methods). The ELISA 
studies  were  performed  using  immobilized  Cx26CT 
peptide and a peptide corresponding to only part of the 
Cx26CL in 0.05% Tween 20 at 4°C. Despite these differ-
ences, the results tell a qualitatively self-consistent story. 
Unfortunately, attempts to lower the pH caused signifi-
cant precipitation of the peptides at the concentrations 
required to obtain NMR spectra.
Proposed domain-level mechanism(s)
The ELISA studies show that AS disrupts the CL3–CT 
interaction. The NMR data show that AS binds to the 
CL only and provide further evidence that AS disrupts 
the CL–CT interaction. Collectively with the functional 
studies, these data suggest the following scenario. At 
normal pH, the Cx26CT and Cx26CL interact to some 
degree. As pH becomes acidic, the interaction between 
the  CT  and  CL  becomes  stronger.  With  increasing 
and CT and its involvement in channel gating have been 
demonstrated for Cx43 and several other members of 
the  family of connexins (Stergiopoulos et al., 1999) 
(http://www.genenames.org/genefamily/gj.php). This 
is the first demonstration of an intramolecular interac-
tion between cytoplasmic domains for the  family of 
connexins, which in addition to Cx26 includes Cx25, 
Cx30, Cx30.3, Cx30.1, Cx31.1, and Cx32. It is somewhat 
unexpected that the CT of Cx26 would be involved in 
interdomain interactions and in gating, as it has been 
regarded as being too short to have regulatory effects.
The finding that in Cx26 the CL–CT interaction is fa-
vored by acidic pH allows for an intriguing comparison 
with pH gating in other connexins. In the previously de-
scribed cases where a pH-driven CL–CT interaction has 
been established, all involving  connexins, this interac-
tion closes the channel. In contrast, for Cx26 (a  con-
nexin) it does not, but its disruption—in this case by 
AS—does. Furthermore, a cytoplasmic molecule, taurine, 
is  necessary  for  the  pH-dependent  channel  closure. 
Because other cytosolic AS, including l-cysteic acid, 
l-homocysteic acid, and hypotaurine, have similarly been 
shown to be effective modulators of Cx26-containing 
channels, there are likely to be other endogenous ligands 
for  connexin family members. Based on the AS-induced 
pore narrowing of Cx26Tc, we speculate that Cx26CT 
free of interaction with the CL adopts a conformation at 
low pH that leads to pore occlusion, either directly or 
allosterically. On the basis of the AS-induced disruption 
of the CL–CT peptide interaction in the ELISA data, we 
do not favor formation of a stable ternary complex be-
tween the CL, CT, and AS.
The molecular basis of the specific association between 
the Cx26CT peptide and the CL3 peptide is unknown; 
neither peptide contains histidine, whose protonation 
state on the basis of solution pKa would be altered over 
the indicated pH range. However, solution pKas may not 
pertain; local microenvironment can dramatically mod-
ify pKas, bringing acidic or basic side-chain pKas into the 
neutral range (González-Nilo et al., 2002; Harris and 
Turner, 2002; Mukouyama et al., 2004). For example, a 
local hydrophobic environment, such as that in the sec-
ond half of CL3 and the adjacent TM3, favors the un-
charged form of titratable groups and can raise the pKa 
of glutamate, the negative amino acid in CL3, by more 
than 2 pH units. Such modulation of pKas operates in 
pH sensing/sensitivity in other channels (Schulte et al., 
1999; Seifert et al., 1999). The high concentration of 
charged residues in both the Cx26CL3 segment and the 
CT affords ample opportunity for such effects.
AS–CT–CL interactions
The  NMR  data  show  direct  interaction  between  the 
Cx26CT peptide and the full-length Cx26CL peptide at 
pH 7.0. The ELISA data show an interaction between 
the  Cx26CT  peptide  and  only  the 
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the CL with the CT keeps the pore open, and either a   
binary interaction of the CT with the pore itself or an 
allosteric effect of the CT structure at acidic pH closes it.
Homomeric Cx32 channels are insensitive to AS, but 
heteromeric Cx26/Cx32, Cx26/Cx32T, and Cx26/Cx32Tc 
channels are AS sensitive, confirming that an unmodi-
fied  CT  is  required  for  AS-induced  effects,  and  that 
fewer  than  six  Cx26  monomers  in  a  hemichannel   
are required for AS sensitivity (also shown in Locke   
et al., 2004b). AS causes pore narrowing of homomeric 
hemichannels in which the Cx26CT has the short addi-
tion  (Cx26Tc)  but  inhibits  channel  activity  when  the 
same  Cx26  modification  is  in  heteromeric  (Cx26Tc/
Cx32) hemichannels. This suggests that there is some 
interaction between Cx26 and Cx32, which converts 
AS-induced pore narrowing into full closure, as if the 
Cx26CT was unmodified. One possibility is that at low 
pH, Cx26Tc is able to recruit the Cx32CT to participate 
in pore occlusion. There is no obvious sequence simi-
larity between the Cx32 and Cx26 CTs to suggest a basis 
for this, however, except that the initial segment of both 
have a preponderance of positively charged residues. 
An analogous possibility is that the CT of Cx26 re-
cruits involvement of the CL of Cx32. These explana-
tions  would  be  most  readily  consistent  with  direct 
occlusion of the pore by free Cx26 CT or by free Cx26 
CL+AS (mechanisms a and c above, respectively).
When the heteromeric channels contain Cx26 with 
the longer CT addition (Cx26T/Cx32), there is no AS 
sensitivity at all. This is expected because homomeric 
Cx26T channels are insensitive. The inability of Cx32 to 
reinstate the sensitivity to AS in this case suggests that 
the additional length of the CT in Cx26T blocks the 
compensatory interaction with Cx32 that occurs in the 
Cx26Tc/Cx32 channels. Moreover, the Cx32CT is sig-
nificantly  longer  (69  amino  acids;  approximately  six-
fold) than the Cx26CT; in effect, the native Cx32CT 
mimics a Cx26CT with a large purification tag.
Relation to CL–CT interactions in other connexins
As noted above, the intramolecular basis of pH-driven 
gating in Cx43, an exemplar of the  connexin family, 
has been well described (Hirst-Jensen et al., 2007). Al-
though it also involves interactions between the CT and 
the second half of the CL (a peptide called “L2”), there 
are strikingly different functional consequences. In Cx43, 
acidic conditions protonate histidine(s) in the L2, driv-
ing formation of an  helix that interacts with part of 
the CT, leading to occlusion of the channel pore.
The notion of dynamic interactions between CL and 
CT domains of connexins is supported by AFM studies 
indicating high structural flexibility of the cytoplasmic 
domains of Cx26, Cx40, and Cx43 (Müller et al., 2002; 
Liu et al., 2006; Allen et al., 2011), which could also be 
inferred from the inability to resolve these domains in the 
x-ray crystal structure (Maeda et al., 2009). AFM studies 
concentration of cytoplasmic AS, the CL–CT interaction is 
disrupted, which leads to channel closure. Channel clo-
sure could be effected by any of several consequences of 
the disruption of the CL–CT interaction. These include: 
(a) the free CT physically blocks the pore at low pH, but 
not at normal pH; (b) the free CT at low pH interacts 
with another connexin domain, which closes the pore 
directly or allosterically; (c) the CL at low pH, when free 
of  interaction  with  the  CT  and  interacting  with  AS, 
physically blocks the pore; and (d) the CL at low pH, 
free of interaction with the CT and interacting with AS, 
allosterically blocks the pore, alone or via interaction 
with another connexin domain.
If the CT is the active component (a and b above), the 
long addition to it (tag [T]) would render it unable to 
block the pore, directly or allosterically. Alternatively, 
the long addition could disable the ability of AS to dis-
rupt the CL–CT interaction. The fact that the short 
addition (cleaved tag [Tc]) retains an AS effect (pore 
narrowing) argues most simply that, if the CT is the ef-
fective element, it directly occludes the pore, and that 
the short addition interferes with complete occlusion. 
One could imagine a less likely scenario of modulation 
by an allosteric effect, however. That an AS effect is re-
tained with the small addition suggests that it does not 
interfere with the CL–CT interaction.
If the CL is the active component (c and d above), the 
long addition to the CT could disable the ability of AS 
to disrupt the CL–CT interaction or the ability of the 
free CL to effect pore closure. The short addition to the 
CT, which retains an AS sensitivity, could affect CL–CT 
complex formation but compromise direct or allosteric 
CL-mediated channel closure.
Put in other terms, the data suggest either that in 
wild-type proteins at low pH the CT is tied up by the CL 
so that it cannot cause channel closure unless AS is pres-
ent, or that the CT ties up the CL so that it cannot close 
the channel unless AS is present.
Both scenarios involve two effects of acidic pH: struc-
tural effects on the CT and/or CL that enable pore oc-
clusion,  and  the  coordinated  (and  perhaps  related) 
increase of their affinity of interaction so that this does 
not occur. The CT–CL interaction is dominant (keep-
ing the channel open), unless disallowed by the pres-
ence of AS, in which case the channel is occluded.
Previous  work  had  suggested  two  possible  mecha-
nisms: one in which a binary interaction between either 
AS or the CT interacted with a “receptor” domain (shown 
here to involve a segment of the CL closest to TM3)   
to close the channel, and one in which a ternary inter-
action between the AS, the CT, and the receptor do-
main closes the channel (Bevans and Harris, 1999). The 
present  work  reveals  a  mechanism  that  combines   
elements of both: the binary interaction of AS with the 
CL does not in itself close the pore, and neither does a 
ternary interaction. At acidic pH, a binary interaction of 336 Taurine gating of connexin26-containing channels
PTMs of acidic residues (i.e., potential amine-binding 
sites) in the Cx26CL were also observed, as well as other 
modifications  of  the  CL.  None  were  detected  in  the 
CL3 portion (which had poor peptide ionization as a 
result of the hydrophobicity of this segment), but if res-
idues in the CL3 portion of the CL are so modified, they 
could affect AS sensitivity.
Correlation with in vivo conditions
The  studies  of  channel  function  reported  here  use 
hemichannels reconstituted into liposomes, and hemi-
channels  and  junctional  channels  expressed  in  cells. 
The molecular interactions that underlie this modula-
tion of channel activity were explored using different 
biochemical techniques and several peptide reagents. 
Despite all of the differences in experimental strategies 
and  conditions,  the  effects  of  AS  and  of  the  various   
CT alterations on AS sensitivity are highly correlated in 
all functional assays (activity and permeability studies 
of channels in liposomes and in native cells), channel 
forms (hemichannels and junctional channels), and 
molecular interaction studies (ELISA and NMR).
TSF, ELISA, and NMR conditions differ from those in 
cells. In addition, the behavior of the peptide segments 
will be affected by integration into the full connexin 
protein and by the quaternary structure of the channel 
in a membrane environment. Also, although no acces-
sory proteins that affect Cx26 channel function have yet 
been identified, the possibility exists. Because of these 
factors, one should not presume that all inferences de-
rived from studies of peptides will be directly applicable 
without modification to cellular physiology. However, 
we note that for many proteins, including Cx43, study 
of model peptides has been informative regarding func-
tion of intact channels in cells.
In the present study, taurine was used as the AS be-
cause of its ubiquitous yet inhomogeneous presence in 
biological tissues. Taurine is involved in a multitude of 
cellular processes, including anti-oxidation, modulation 
of cytosolic Ca
2+ levels, and osmoregulation (Huxtable, 
1992; Foos and Wu, 2002; Wu et al., 2005; Lambert et al., 
2008; Schaffer et al., 2009; Pan et al., 2010). Its concen-
tration in cells varies widely and is a function of the 
activities of several biosynthetic enzymes and taurine 
transporters, which are dynamically regulated (Huxtable, 
1992; Lambert, 2004; Tappaz, 2004; Han et al., 2006). 
In this report, taurine is used as a tool, albeit with po-
tential biological relevance, to explore molecular inter-
actions involved in connexin channel gating.
To date, there are no hard data pointing to cytosolic 
taurine as a biologically used mechanism for modula-
tion  of  connexin  channel  function,  although  it  has 
been inferred (Locke et al., 2004b). However, we note 
that the action of taurine on Cx26-containing channels 
is shared by other cytoplasmic AS (e.g., l-cysteic acid, 
l-homocysteic acid, hypotaurine), some of which are 
have also shown changes in the conformations of the cyto-
plasmic domains of Cx40 and Cx43, with channel gating 
induced by Ca
2+(Liu et al., 2006; Allen et al., 2011).
At present, there is no structural information about 
pH-induced  changes  in  secondary  structure  of  the 
Cx26CL. Overall, there is little sequence similarity be-
tween the relevant segments (L2 of Cx43 and CL3 of 
Cx26). However, there is considerable similarity in a 
small segment of the first half of CL3 and the latter half 
of L2 (Fig. 6 A). It is tempting to think that this se-
quence and similarity of charge patterns play roles in 
structural responses to pH and interaction with the re-
spective CTs.
A recent study examined the -helical content of pep-
tides  corresponding  to  various  connexin  domains  in 
the presence of trifluoroethanol, which tends to stabi-
lize secondary structure (Fort and Spray, 2009). The 
propensity to form  helices thus revealed was substan-
tial and equivalent for peptides corresponding to the 
L2 peptide of Cx43 and the CL3 peptide of Cx32. The 
overall similarity of the CL3 segments of Cx26 and Cx32 
noted above suggests that the same propensity exists for 
Cx26 (Fig. 6 A), consistent with the transition in sec-
ondary structure of Cx43 that enables interaction with 
its CT.
Mutations and posttranslational modifications (PTMs) of 
the Cx26 CT and CL
Prior to this work, a functional or structural role for the 
Cx26CT in channel physiology was unknown. In other 
connexins, the CT is much longer and often contains 
sites for PTM (e.g., phosphorylation) as well as protein–
protein interaction (e.g., SH2/PDZ-binding segments) 
(Sorgen et al., 2004; Solan and Lampe, 2009). As noted 
above, the CT of Cx26 has been considered too short to 
play an important functional role, be it involving PTMs 
or inter/intramolecular interactions.
However, several mutations that affect the Cx26CT 
cause  nonsyndromic  deafness  (http://davinci.crg.es/
deafness/index.php). A two-nucleotide deletion in codon 
211 terminates the protein four codons later, eliminat-
ing the entire CT (Kelley et al., 1998). A four-base dele-
tion starting in codon 215 causes a frameshift (Prasad   
et al., 2000). The CT deafness mutation L214P does not 
form functional channels (Meşe et al., 2004). Of interest, 
the deafness mutation K224Q (Antoniadi et al., 2000), 
which eliminates a basic, potential sulfonate-binding site 
on the Cx26CT, also does not form functional channels. 
Unfortunately, it is unknown whether the K224Q muta-
tion interferes with channel biogenesis, trafficking, or 
plasma membrane insertion.
Channel function can also be modulated by PTMs. 
Mass spectrometry analysis indicated that either K221 
or K223 in the Cx26CT could be methylated (Locke et al., 
2009). This would not alter charge but would increase 
residue hydrophobicity and “bulk” of the CT. Several   Locke et al. 337
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